Net Cash Provided by (Used in) Operating Activities |
-10.5K |
USD |
-174% |
Jul 31, 2023 |
Q2 2023 |
Net Cash Provided by (Used in) Financing Activities |
2.5K |
USD |
-35.1% |
Jul 31, 2023 |
Q2 2023 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Shares, Issued |
139M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-8.05K |
USD |
-804500% |
Jul 31, 2023 |
Q2 2023 |
Deferred Tax Assets, Valuation Allowance |
300K |
USD |
-6.54% |
Apr 30, 2023 |
Q1 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Apr 30, 2023 |
Q1 2022 |
Deferred Tax Assets, Gross |
300K |
USD |
-6.54% |
Apr 30, 2023 |
Q1 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.15M |
USD |
+9.12% |
Apr 30, 2022 |
Q1 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Jan 31, 2024 |
Q4 2023 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Additional Paid in Capital |
452K |
USD |
0% |
Jan 31, 2024 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Jan 31, 2024 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Apr 30, 2022 |
Q1 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |